NeuroEndocrine Cancer Australia & Macquarie University study on important online resources for NET patients. May 2, 2022
Expression-of-Interest for consumer participation on Grant Review Committees for the 2022 Priority-driven Collaborative Cancer Research Scheme April 27, 2022
Provectus Biopharmaceuticals Announces Presentation of Full Study Data from Metastatic Neuroendocrine Cancer Phase 1 Trial of PV-10® at European Society for Medical Oncology (ESMO) Congress 2021 September 27, 2021
Real-world management and patient perspectives on QOL with neuroendocrine tumours: An ANZ perspective July 27, 2021
